| Product NDC: | 0013-0101 | 
| Proprietary Name: | Azulfidine | 
| Non Proprietary Name: | SULFASALAZINE | 
| Active Ingredient(s): | 500 mg/1 & nbsp; SULFASALAZINE | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0013-0101 | 
| Labeler Name: | Pharmacia and Upjohn Company | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA007073 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19500620 | 
| Package NDC: | 0013-0101-11 | 
| Package Description: | 100 TABLET in 1 BOX, UNIT-DOSE (0013-0101-11) | 
| NDC Code | 0013-0101-11 | 
| Proprietary Name | Azulfidine | 
| Package Description | 100 TABLET in 1 BOX, UNIT-DOSE (0013-0101-11) | 
| Product NDC | 0013-0101 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | SULFASALAZINE | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 19500620 | 
| Marketing Category Name | NDA | 
| Labeler Name | Pharmacia and Upjohn Company | 
| Substance Name | SULFASALAZINE | 
| Strength Number | 500 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] |